ResMed | RMD - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Ansell USD 605.3M 351.2M 2025-12
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 34.98M 3.04M 2026-06
Baxter International USD 1.93B 118M 2026-06
Cochlear AUD 319.2M 160.35M 2025-12
Cooper Companies USD 401.3M 7.5M 2026-06
CSL USD 3.87B 2.08B 2025-12
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Fisher Paykel Healthcare NZD 435.5M 32.7M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Haemonetics USD 136.58M 11.56M 2026-06
Idexx Laboratories USD 437.5M 19.42M 2026-06
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 239.1M 6.4M 2026-06
Integra LifeSciences USD 186.73M 2.13M 2026-09
Intuitive Surgical USD 964.4M 32.5M 2026-09
Medtronic USD 3.83B 26M 2026-06
Philips EUR 2.21B 70M 2026-06
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 612.93M 61.26M 2026-06
Sigma Healthcare AUD 1.55B 165.16M 2024-12
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Steris USD 808.6M 82.7M 2026-06
Teleflex USD 238.62M 2.21M 2026-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06